Maravai LifeSciences Holdings, Inc.
Maravai LifeSciences Holdings, Inc.
Your view on MRVI
Overview
What the company does, where it operates, and who runs it.
About Maravai LifeSciences Holdings, Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Bernd Brust
- Headquarters
- 10770 Wateridge Circle, San Diego, CA, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Bernd Brust
- Headquarters
- 10770 Wateridge Circle, San Diego, CA, US
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally.
The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species.
It operates in two segments, Nucleic Acid Production and Biologics Safety Testing.
The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA).
This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as plasmid DNA and CleanCap capping technology.
The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, and custom services.
The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. Maravai LifeSciences Holdings, Inc. was incorporated in 2020 and is headquartered in San Diego, California.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Maravai LifeSciences Holdings, Inc., and the rating behind it. MRVI last traded at $6.53; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Maravai LifeSciences Holdings, Inc.. Starting points for Maravai LifeSciences Holdings, Inc.: EPS -$0.52, beta 0.60 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Maravai LifeSciences Holdings, Inc.. Maravai LifeSciences Holdings, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Maravai LifeSciences Holdings, Inc.. Trailing twelve-month EPS for Maravai LifeSciences Holdings, Inc. stands at -$0.52. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Maravai LifeSciences Holdings, Inc.. Maravai LifeSciences Holdings, Inc. has reported as a listed company since 2020. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Maravai LifeSciences Holdings, Inc. valued side by side against its closest peers. Maravai LifeSciences Holdings, Inc. is measured against Biotechnology peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Maravai LifeSciences Holdings, Inc., and how their positions are changing. At a $1.80B market value, institutional positions materially move Maravai LifeSciences Holdings, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Maravai LifeSciences Holdings, Inc. executives and directors. Shares of Maravai LifeSciences Holdings, Inc. have traded between $1.67 and $6.21 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Maravai LifeSciences Holdings, Inc.. Maravai LifeSciences Holdings, Inc. is a $1.80B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Maravai LifeSciences Holdings, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Maravai LifeSciences Holdings, Inc.. Coverage tracks Maravai LifeSciences Holdings, Inc. within Biotechnology (Healthcare). Press releases and market coverage, newest first.